Increases the efficiency of drug discovery and disrupts the billion dollar per compound cost of bringing a new therapeutic into the market.
PathDrugomics exponentially increases the efficiency of drug discovery and disrupts the billion dollar per compound cost of bringing a new therapeutic into the market. Our products utilize the speed of accelerating computational technologies and the intelligence of big data analytics to model interactions between newly discovered drugs and their possible targets within diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 10, 2013 | Seed | $28K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Alchemist Accelerator | — | Seed |